Oral submucous fibrosis as a precancerous condition
- PMID: 6589738
- DOI: 10.1111/j.1600-0722.1984.tb00883.x
Oral submucous fibrosis as a precancerous condition
Abstract
An evaluation of the malignant potential of submucous fibrosis, based on observations of 89 patients with the disease in Ernakulam District, Kerala, India was done. Out of the 89 patients, 12 were referred patients and 77 were diagnosed in population based studies. At the time of first examination oral cancer was found to be coexistent in nine (10%) cases. For 66 patients follow-up observations ranging from 4 to 15 yr (median 8 yr) were available. During this period malignant transformation was observed in three patients (4.5%). Considering malignant transformation and coexistence together, oral cancer was observed in 13% of the present material. Leukoplakia was found in 26% of the patients with submucous fibrosis. Out of 42 submucous fibrosis patients biopsied, 12% showed squamous cell carcinoma, 26% epithelial dysplasia, and 76% atrophic epithelium. These findings reinforced the hypothesis that submucous fibrosis is a precancerous condition.
Similar articles
-
Malignant transformation rate in oral submucous fibrosis over a 17-year period.Community Dent Oral Epidemiol. 1985 Dec;13(6):340-1. doi: 10.1111/j.1600-0528.1985.tb00468.x. Community Dent Oral Epidemiol. 1985. PMID: 3866655
-
Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital.J Oral Pathol Med. 2007 Jan;36(1):25-9. doi: 10.1111/j.1600-0714.2006.00491.x. J Oral Pathol Med. 2007. PMID: 17181738
-
Oral submucous fibrosis as a precancerous lesion.J Dent Assoc S Afr. 1982 Aug;37(8):521-6. J Dent Assoc S Afr. 1982. PMID: 6964201 No abstract available.
-
Oral submucous fibrosis: An update on pathophysiology of malignant transformation.J Oral Pathol Med. 2017 Jul;46(6):413-417. doi: 10.1111/jop.12582. Epub 2017 May 6. J Oral Pathol Med. 2017. PMID: 28391621 Review.
-
Oral submucous fibrosis: an unusual disease.J N J Dent Assoc. 1997 Spring;68(2):17-9. J N J Dent Assoc. 1997. PMID: 9540735 Review. No abstract available.
Cited by
-
Management of oral submucous fibrosis by two different drug regimens: A comparative study.Dent Res J (Isfahan). 2013 Jul;10(4):527-32. Dent Res J (Isfahan). 2013. PMID: 24130591 Free PMC article.
-
Serum aflatoxin B1 antibody titer, percent hemolysis and transaminases in oral submucous fibrosis.J Oral Maxillofac Pathol. 2021 Jan-Apr;25(1):110-117. doi: 10.4103/jomfp.JOMFP_226_20. Epub 2021 May 14. J Oral Maxillofac Pathol. 2021. PMID: 34349420 Free PMC article.
-
Role of areca nut induced JNK/ATF2/Jun axis in the activation of TGF-β pathway in precancerous Oral Submucous Fibrosis.Sci Rep. 2016 Oct 6;6:34314. doi: 10.1038/srep34314. Sci Rep. 2016. PMID: 27708346 Free PMC article.
-
Dentoalveolar surgery in oral submucous fibrosis: need for caution.J Maxillofac Oral Surg. 2013 Sep;12(3):341-2. doi: 10.1007/s12663-012-0421-3. Epub 2012 Aug 26. J Maxillofac Oral Surg. 2013. PMID: 24431865 Free PMC article. Review.
-
MIAT promotes myofibroblastic activities and transformation in oral submucous fibrosis through sponging the miR-342-3p/SOX6 axis.Aging (Albany NY). 2024 Oct 7;16(19):12909-12927. doi: 10.18632/aging.206121. Epub 2024 Oct 7. Aging (Albany NY). 2024. PMID: 39379100 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Medical